677
Views
8
CrossRef citations to date
0
Altmetric
Review

Host factors affecting oral candidiasis

&
Pages 18-21 | Received 08 Jun 2010, Accepted 31 Aug 2010, Published online: 15 Jul 2015

References

  • Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP MacFarlane TW, (eds) Oral Candidosis. London: Wright, 1990; 66–103
  • Bastiaan RJ, Reade PC. The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses. Oral Surg Oral Med Oral Pathol 1982; 53:148–151
  • Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994; 23: 406–412
  • Kashima M, Takasahi H, Shimozuma M, Epstein WL, Fukuyama K. Candidacidal activities of proteins partially purified from rat epidermis. Infect Immun 1989; 57:186–190
  • I9ng RD, Lee JC, Monis AL. Adherence of Candida albicans and other Candida species to mucosal ephelial cells. Infect Immun 1980; 27:667–674
  • Marshall KC. Interlaces in microbial ecology. Cambridge: Harvard University Press, 1976; 1–11
  • Hazen KC, Glee PM. Hydrophobic cell wall protein glycosylation by the pathogenic fungus Candida albicans. Can J Microbio11994; 40:266–272
  • Bailey A, Wadsworth E, Calderone R. Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signaling events. Infect Immun 1995; 63:569–572
  • Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis? J Dent Res 1995; 74:1152–1161
  • Odds FC. Candida and Candidosis: A Review and Bibliography, 2nd ed. London: Baillière Tindall, 1988
  • Ollert MW, Calderone RA. A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-reacts with yeast cell protoplasts. Infect Immun 1990; 58: 625–631
  • Ponton J, Marot-Leblond A, Ezkurra PA, Barturen B, Robert R, Senet JM. Characterization of Candida albicans cell wall antigens with monoclonal antibodies. Infect Immun 1993; 61:4842–4847
  • Kimura LH, Pearsall NN. Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells. Infect Immun 1980; 28:464–468
  • Samaranayake LP MacFarlane TW. Factors affecting the in vitro adherence of the fungal oral pathogen Candida albicansto epithelial cells of human origin. Arch Oral Bio11982; 27: 869–873
  • Odds FC. Candida species and virulence. ASM News 1994; 60:313–318
  • Santoni G, Gismondi A, Liu JH, Punturieri A, Santoni A, Frati L Candida albicans expresses a fibronectin receptor antigenically related to α5β1 integrin. Microbiology 1994; 140:2971–2979
  • Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Infect Dis 1971; 123:371–377
  • Samaranayake LP Calman KC, Ferguson MM. The oral carriage of yeasts and colifomis in patients on cytotoxic therapy. J Oral Patho1 1984; 13:390–393
  • Samaranayake LP Hughes A, Weetman DA, MacFarlane TW. Growth and acid production of Candida species in human saliva supplemented with glucose. J Oral Pathol 1986; 15: 251–254
  • Challacombe SJ. Immunology of oral candidosis. In: Samaranayake LP MacFarlane T1V, eds. Oral candidosis. London: Butterworth, 1990; 104–123
  • Scully C, El-Kabir M, Samaranayake LP. Candida and oral candidosis: a review. Grit Rev Oral Biol Med 1990; 5: 125–157
  • Lamey, P-J, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J 1988; 296: 1243–1246
  • Samaranayake LP Lamey P-J, Lamb AB, MacFarlane TIN. Oral carriage of Candida species and col iforms in patients with burning mouth syndrome. J Dial Pathol 1989; 18:233–235
  • Samaranayake LP Robertson AG, MacFarlane T1V. The effect of chlotexidine gluconate and benzylamine mouth-washes on mucositis induced by therapeutic irradiation. Clin Radiol 1988; 39: 291–294
  • Makrides HC, MacFarlane T1V. Effect of commensal bacteria on the adherence of Candida albicans to ephelial cells in vitro. Microbios 1982; 21: 55–61
  • Centeno A, Davis CP, Cohen MS, Warren MM. Modulation of Candida albicans attachment to human epithelial cells by bacteria and carbohydrates. Infect Immun 1983; 39:1354–1360
  • Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980; 25:1–10
  • Shipman B. Clinical evaluation of oral Candida in cancer chemotherapy patients. J Prosthet Dent 1979; 41:63–67
  • Samaranayake LP MacFarlane TIN.An in vitro study of the adherence of Candida albicansto acrylic surfaces. Arch Oral Biol 1980; 25: 603–609
  • Heimdahl A, Nord CE. Oral yeast infections in immuno-compromised and seriously diseased patients. Acta Odontol Scand 1990; 48:77–84
  • Diamond RD. Interactions of phagocytic cells with Candida and other opportunistic fungi. Arch Med Res 1993; 24: 361–369
  • Greenfield RA. Host defense system interactions with Candida. J Med Vet Mycol 1992; 30:89–104
  • Kerridge DK. Fungal dimorphism: a sideways look. In: Vanden Bossche H, Odds FC, Kerridge D, eds. Dimorphic fungi in biology and medicine. New York: Plenum Press, 1993; 3–10
  • Sherwood J, Gow NAR, Gooday GW, Gregory DW, Marshall D. Contact sensing in Candida albicans: a possible aid to epithelial penetration. J Med Vet Mycol 1992; 30:461–469
  • Soll DR. High-frequency svOching in Candida albicans. Clin Mkrobiol Rev 1992; 5:183–203
  • Warnock DW. Introduction to the management of fungal infection in the compromised patient. In:Warnock DW, Richardson MD, eds. Fungal infection in the compromised patient, 2nd ed. Chichester: John Wiley, 1991; 23–53
  • Odds FC, Evans EGV, Taylor MAR, Wales JK. Prevalence of pathogenic yeasts and humoral antibodies to Candida in diabetic patients. J Clin Pathol 1987; 31:840–844
  • Tapper-Jones L, Aldred M, Walker DM, Hayes TM. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 34:706–711
  • Fisher BM, Lamey P-J, Samaranayake LP, MacFarlane TW. Carriage of Candida species in the oral cavhr in diabetic patients: relationship to glycaemic control. J Oral Pathol 1987; 16: 282–284
  • Wilson RM, Reeves WG. Neutrophil phagocytosis and Idlling in insulin-dependent diabetes. Clin Erp Immunol 1986; 63:478–484
  • Farman AG, Nutt G. Oral Candida, debilitating disease and atrophic lesions of the tongue. J Biol Buccale 1976; 4: 203–226
  • Darwazeh A, Lamey P-J, Samaranayake LP, MacFarlane TW. The relationship between colonisation, secretor status and in vitro adhesion of Candida to buccal epithelial cells from diabetics. J Med Microbiol 1990; 33: 43–49
  • Coleman DC, Bennett DE, Sullivan DJ, Gallagher PJ, Henman MC, Shanley DB. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Grit Rev Microbio11993; 19: 61–82
  • Lal S, Chussid S. Oral Candidiasis in paediatric HIV patients. NY State Dentistry J 2005; 71(2): 28–31
  • Coogan M., Fidel PL, Komesu MC, Maeda N, Samaranayake LP. (B1) Candida and mycotic infections. Adv Dent Res 2006; 19(1): 130–138
  • Menon T, Umamaheswari K, Kumarasamy N, Solomon S, Thyagarajan SR Efficacy of flucanazole and itraconazole in the treatment of oral candidiasis in HIV patients. Acta Trop 2001; 80(2): 151–154
  • Costa CR, De Lemos JA, Passos XS, et al Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia 2006; 162(1): 45–50
  • Wingeter MA, Guilhermetti E, Shinobu CS, Takald I, Svidzinsld TI. Microbiological identification and in vitro sensitivity of Candida isolates from the oral cavity of HIV-positive individuals. Rev Soc Bras Med Trop 2007; 40(3): 272–276
  • Woldeamanuel Y, Abate D. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients. Ethiop Med J 1998; 36(4):235–243
  • Klein RS, Harris CA, Small CB, Moll B, Lesser M, Freedland GH. Oral candidiasis in high-risk patients as the idal manffestation of the acquired immunodeficiency syndrome. N Eng J Med 1984; 311: 354–358
  • Farmon J, Tadan A, Rosenthal LE. Focal esophageal candidiasis in acquired immunodeficiency syndrome. Gasfrointest Radiol 1986; 11:213–217
  • Holmstrup P, Samaranayake LP. Acute and AIDS-related oral candidosis. In: Samaranayake LP, MacFarlane TW. Eds. Oral candidosis. London: Butterworth, 1990; 133–155
  • Hauman CHJ, Thompson IOC, Theunissen F, Wolf aardt R Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993; 76:570–572
  • Hersch EM, Gutterman JU, Mavligit GM. Effect of haematological malignancies and their treatment on host defense factors. Clin Haematol 1976; 5:425–448
  • Samaranayake LP. Nutritional factors and oral candidosis. J Oral Pathol 1986; 15: 61–65
  • Rennie JS, MacDonald DG. Quantitative histological analysis of the epithelium of the ventral surface of hamster tongue in experimental iron deficiency. Arch Oral Biol 1982; 27: 393–397
  • Joynson DH, Walker DM, Jacobs A. Dolby AE. Defects of cell mediated immunity in patients with iron deficient anaemia. Lancet 1972; 2:1058–1059
  • Wilton JM, Lehner T. Immunology of Candidiasis. In: Nahmias EJ, O’Reilly RJ, eds. Immunology of Human Infection. New York: Plenum Medical, 1981; 525–559
  • Rennie JS, MacDonald DG, Dagg JH. Iron and the oral epithelium:A review. J Royal Sac Med 1984; 77:602–607
  • Cawson RA. Denture sore mouth and angular cheilitis. Br Dent J 1963; 15:441–449
  • Fletcher J, Mather J, Lewis MJ, Whiting G. Mouth lesions in iron-deficient anaemia: Relationship to Candida albicans in saliva and to impairment of lymphocyte transformation. J Infect Dis 1975; 131:44–48
  • Higgs JM, Wells RS. Chronic mucocutaneous candidosis: associated abnormalities of iron metabolism. Br J Dermatol 1972; 86(8): 88–102
  • Ferguson MM. Oral mucous membrane markers of internal disease. In: Dolby AD, ed. Oral Mucosa in Health and Disease, 1st edn. Oxford: Blackwell, 1975; 233–301
  • Dennis M, ltkin IH. Effectiveness and complications of aerosol dexamethasone phosphate in severe asthma. J Allergy 1964; 35:70–76
  • Stead RJ, Cooke NJ. Adverse effects of inhaled corticosteroids. Br Med J 1989; 298:403–404
  • Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982; 65:134–155
  • Peterson DE, Sonis TS. Oral complications of cancer chemotherapy. The Hague: Martinus Nijhoff Publishers, 1983
  • Martin MV, Al-Tikriti V, Bramley R Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer. J Med Mkrobiol 1981; 14: 457–467
  • Main BE, Calman KC, Ferguson MM, Kaye SB, MacFarlane TIN, Mains RJ, Samaranayake LP Willox J, Welsh J. The effects of cytotoxic therapy on saliva and oral flora. Oral Sung Oral Med Oral Pathol 1984; 58:545–548